Painkiller overdoses are killing 116 people, every day. CNBC's "On the Money" asks the co-director of the Johns Hopkins Center for Drug Safety what needs to be done to reverse this growing public health threat. » Read More
By: By Alyson Krueger
People are using genetic testing sites to discover and meet new family members, creating a new form of social network. » Read More
By: Eric Rosenbaum
Consumer DNA genetic-testing kits are a booming business, and the biggest risk isn't necessarily uncovering a health scare; it's what these companies may do with your genetic data. » Read More
Jim Cramer reveals how the moves in NXP Semiconductors and Qualcomm could hint at what’s to come in the U.S.-China trade battle. » Read More
The Securities and Exchange Commission in March accused Holmes of "massive fraud" in connection with Theranos.
Many pregnant women have been sidelined in the workplace. They’ve been passed over for promotions and raises and some were even fired when they complained, The New York Times reports.
The company plans to open a new 200,000-square foot space in Chicago's Old Post Office Building in the fall of 2019.
Cedric Meury noticed something very strange about the kit he received from a start-up called Dante Labs.
Amid the battle over who benefits the most from increasing prescription drug prices, Eli Lilly CEO David Ricks says, "It's time for a change" to the system.
Kentucky Attorney General Andy Beshear filed the suit against Walgreens for its dual role as a distributor and a pharmacy.
Four recently posted job openings for a "medical digital assist" project hint at how Google's trying to make doctors' lives easier.
Nights alone at a hotel. Hours spent in an airport. Missing your family. A new study looks at the mental wear and tear of frequent business travel.
Mylan said U.S. health regulators were unable to approve its generic version of GlaxoSmithKline's blockbuster inhaled lung drug Advair for the second time.
See which stocks are posting big moves after the bell.
Amazon and AT&T pursued the deal in part due to new competition from video streaming services like Netflix and Amazon.
Medications that are common in the homes of one-third of US adults may cause depression — even those that have nothing to do with mood or anxiety, according to a new study. USA Today reports.
Medical device maker Stryker was not in discussions to buy rival Boston Scientific, Stryker said in a regulatory filing on Wednesday.
Shares of drugstore CVS Health jump after a federal judge approved AT&T's bid for Time Warner.
According to researchers at PwC, the big goal next year is to try to insulate workers from rising health costs.
Jim Cramer breaks down how shares of RH could continue to soar.